Signaling molecules, transcription growth factors and other regulators revealed from in-vivo and in-vitro models for the regulation of cardiac development

被引:48
|
作者
Meganathan, Kesavan
Sotiriadou, Isaia
Natarajan, Karthick
Hescheler, Juergen
Sachinidis, Agapios [1 ,2 ]
机构
[1] Univ Cologne, Inst Neurophysiol, Ctr Physiol & Pathophysiol, D-50931 Cologne, Germany
[2] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany
关键词
Cardiac development; Embryonic stem cells; Wnt signaling; Long noncoding RNA; MicroRNA; Transcription factors; Small molecules; EMBRYONIC STEM-CELLS; 2ND HEART FIELD; EPITHELIAL-MESENCHYMAL TRANSITION; ACTIN EXPRESSING CARDIOMYOCYTES; TGF-BETA; WNT/BETA-CATENIN; FUNCTIONAL-CHARACTERIZATION; PROGENITOR CELLS; GENE-EXPRESSION; MIR-17-92; CLUSTER;
D O I
10.1016/j.ijcard.2015.01.049
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several in-vivo heart developmental models have been applied to decipher the cardiac developmental patterning encompassing early, dorsal, cardiac and visceral mesoderm as well as various transcription factors such as Gata, Hand, Tin, Dpp, Pnr. The expression of cardiac specific transcription factors, such as Gata4, Tbx5, Tbx20, Tbx2, Tbx3, Mef2c, Hey1 and Hand1 are of fundamental significance for the in-vivo cardiac development. Not only the transcription factors, but also the signaling molecules involved in cardiac development were conserved among various species. Enrichment of the bone morphogenic proteins (BMPs) in the anterior lateral plate mesoderm is essential for the initiation of myocardial differentiation and the cardiac developmental process. Moreover, the expression of a number of cardiac transcription factors and structural genes initiate cardiac differentiation in the medial mesoderm. Other signaling molecules such as TGF-beta, IGF-1/2 and the fibroblast growth factor (FGF) play a significant role in cardiac repair/regeneration, ventricular heart development and specification of early cardiac mesoderm, respectively. The role of the Wnt signaling in cardiac development is still controversial discussed, as in-vitro results differ dramatically in relation to the animal models. Embryonic stem cells (ESC) were utilized as an important in-vitro model for the elucidation of the cardiac developmental processes since they can be easily manipulated by numerous signaling molecules, growth factors, small molecules and genetic manipulation. Finally, in the present review the dynamic role of the long noncoding RNA and miRNAs in the regulation of cardiac development are summarized and discussed. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:117 / 128
页数:12
相关论文
共 50 条
  • [1] BEAN COTYLEDON PROTEASE ACTIVITY IN-VIVO AND IN-VITRO IN RELATION TO GROWTH-REGULATORS
    YOMO, H
    SRINIVASAN, K
    PLANT PHYSIOLOGY, 1972, 49 : 47 - +
  • [2] MULTIFACTORIAL REGULATION OF CARDIAC GENE-EXPRESSION - AN IN-VIVO AND IN-VITRO ANALYSIS
    SAMUEL, JL
    DUBUS, I
    FARHADIAN, F
    MAROTTE, F
    OLIVIERO, P
    MERCADIER, A
    CONTARD, F
    BARRIEUX, A
    RAPPAPORT, L
    CARDIAC GROWTH AND REGENERATION, 1995, 752 : 370 - 386
  • [3] Carvacrol Ameliorates Pathological Cardiac Hypertrophy in Both In-vivo and In-vitro Models
    Jamhiri, Mohabbat
    Dahaj, Farzan Safi
    Astani, Akram
    Hejazian, Seyed Hasan
    Haflzibarjin, Zeynab
    Ghobadi, Mojtaba
    Moradi, Ali
    Khoradmehr, Arezu
    Safari, Fatemeh
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2019, 18 (03): : 1380 - 1394
  • [4] INFLUENCE OF CARDIAC MOTION ON DOPPLER MEASUREMENTS USING IN-VITRO AND IN-VIVO MODELS
    CAO, T
    SHAPIRO, SM
    BERSOHN, MM
    LIU, SCK
    GINZTON, LE
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (01) : 271 - 276
  • [5] Pharmacological basis of the antifibrotic effects of pirfenidone: Mechanistic insights from cardiac in-vitro and in-vivo models
    Sartiani, Laura
    Bartolucci, Gianluca
    Pallecchi, Marco
    Spinelli, Valentina
    Cerbai, Elisabetta
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [7] HUMAN BREAST CANCERS RESPOND TO GROWTH-FACTORS IN-VIVO BUT NOT IN-VITRO
    YANG, J
    POPNIKOLOV, NK
    SAKTHIVEL, R
    NANDI, S
    CANCER LETTERS, 1994, 85 (01) : 13 - 21
  • [8] COMPARISONS OF IN-VIVO AND IN-VITRO MODELS OF THE RESPONSE OF OSTEOBLASTS TO HORMONAL-REGULATION WITH AGING
    HOCK, JM
    ONYIA, J
    BIDWELL, J
    CALCIFIED TISSUE INTERNATIONAL, 1995, 56 : S44 - S47
  • [9] IN-VIVO AND IN-VITRO MODELS OF MEDULLOBLASTOMAS AND OTHER PRIMITIVE NEUROECTODERMAL BRAIN-TUMORS OF CHILDHOOD
    TROJANOWSKI, JQ
    FUNG, KM
    RORKE, LB
    TOHYAMA, T
    YACHNIS, AT
    LEE, VMY
    MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1994, 21 (2-3) : 219 - 239
  • [10] Immunomodulatory effects of macrolides in the lung:: Lessons from in-vitro and in-vivo models
    Tsai, WC
    Standiford, TJ
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (25) : 3081 - 3093